Harness the ingenuity of nature to transform small molecule discovery
Location: France
Total raised: $28.88M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.04.2026 | Series A | $23.39M | Daphni |
| 08.10.2024 | Seed | $5.49M | - |
Mentions in press and media 7
| Date | Title | Description |
| 04.04.2026 | Techbio Pioneer Generare Raises €20M for Novel Drug Molecule Discovery | Generare, a Paris-based techbio company, has secured €20 million in Series A funding. The firm is revolutionizing drug discovery by decoding microbial DNA. This unlocks a vast, previously inaccessible chemical space. Generare generates nove... |
| 02.04.2026 | Generare raises $23.2M to discover unknown molecules and advance new drugs Send us a News Tip EXTRACT THE SIGNAL FROM THE NOISE Cookies | Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development using artificial intelligence, announced today it has raised €20 million, about $23.3 million, in an early-stage f... |
| 02.04.2026 | Generare: €20 Million Raised For Techbio Platform Unlocking Novel Drug Molecules | Paris-based techbio company Generare has raised €20 million in a Series A funding round co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners. Founded in 2023, the ... |
| 02.04.2026 | Generare secures €20M to scale molecular discovery platform | Generare, a Paris-based biotechnology company focused on generating molecular data for drug development, has raised €20 million in a Series A funding round. The round was co-led by Alven and Daphni, with participation from existing investor... |
| 08.10.2024 | Generare Raises €5M in Seed Funding | Generare, a Paris, France-based biotechnology company using novel cloning technique for new medicines and molecules hiding in microbes, raised €5M in Seed funding. Backers included Teampact.ventures, Galion.Exe and EU-backed VIVES Partners.... |
| 08.10.2024 | Generare raises €5M to scale the discovery of new medicines and molecules hiding in microbes | Generare, a biotech uncovering the next generation of medicines and high-value molecules hiding in soil bacteria, has raised €5M in Seed funding from Teampact.ventures, Galion.Exe and EU-backed VIVES Partners, to bring its “discovery factor... |
| - | Generare | “Harness the ingenuity of nature to transform small molecule discovery” |